Elscint has reinforced its reputation for ongoing structural change by again reorganizingits nuclear medicine and CT/MRI sales and marketing groups. Changes announced March 1 are intended to give the units clearlydefined lines of responsibility,
Elscint has reinforced its reputation for ongoing structural change by again reorganizingits nuclear medicine and CT/MRI sales and marketing groups.
Changes announced March 1 are intended to give the units clearlydefined lines of responsibility, according to Donald J. Southard,vice president of sales and marketing. The key appointment isthe selection of John Ariatti as business unit director and actingwestern regional manager for CT/MRI.
Ariatti was formerly director of sales, marketing and customersupport for Otsuka Electronics in Fort Collins, CO. Prior to that,he was MRI marketing director and CT business unit manager forToshiba America Medical Systems.
Elscint Ltd., the parent company of Elscint, Inc., purchasedOtsuka's MRI business. Those assets have been renamed ElscintMR, Inc.
Israel Ohana has departed as nuclear medicine product managerand Southard has temporarily assumed that role. Southard joinedElscint as part of a 1994 restructuring effort, after servingas president and CEO of Serviscope, an independent service organizationin Wallingford, CT.
Can Polyenergetic Reconstruction Help Resolve Streak Artifacts in Photon Counting CT?
July 22nd 2024New research looking at photon-counting computed tomography (PCCT) demonstrated significantly reduced variation and tracheal air density attenuation with polyenergetic reconstruction in contrast to monoenergetic reconstruction on chest CT.
Systematic Review: PET/MRI May be More Advantageous than PET/CT in Cancer Imaging
July 18th 2024While PET/MRI and PET/CT had comparable sensitivity for patient-level regional nodal metastases and lesion-level recurrence, the authors of a systematic review noted that PET/MRI had significantly higher accuracy in breast cancer and colorectal cancer staging.
The Reading Room: Racial and Ethnic Minorities, Cancer Screenings, and COVID-19
November 3rd 2020In this podcast episode, Dr. Shalom Kalnicki, from Montefiore and Albert Einstein College of Medicine, discusses the disparities minority patients face with cancer screenings and what can be done to increase access during the pandemic.
FDA Clears Enhanced Mobile CT System with High-Resolution Photon-Counting Technology
July 15th 2024Photon-counting CT-optimized features with the OmniTom Elite system include 30 cm field of view scanning, continuous spiral scanning, and an ultra-high-resolution capability of 0.141 mm resolution.